branchenspezifische Dividenden Samsung Biologics Co.,Ltd.
Aktien
A207940
KR7207940008
A207940
Pharmazeutika
Schlusskurs
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
1’087’000.00 KRW | +3.23% | +8.70% | +14.54% |
23.01. | Samsung Biologics' Q4 Net Attributable Income springt um 11%, Aktien steigen um 4% | MT |
17.01. | Samsung Biologics betritt mit neuer Einrichtung den Markt für Antikörper-Wirkstoff-Konjugate | MT |
Zu einer Liste hinzufügen 0 ausgewählt | Dividendenrendite | Dividendenrendite | KGV | Price to Book | EV / Sales | Marktkap. / EBITDA | Marktkap. / EBIT | Kap. ($) | |
---|---|---|---|---|---|---|---|---|---|
-.--% | -.--% | 77.78x | 7.15x | 16.98x | 41.14x | 59.19x | 54.17 Mrd. | ||
+1,73% | +1,94% | 26.92x | 4.36x | 5.87x | 17.21x | 20.3x | 83.27 Mrd. | ||
+0,75% | +0,77% | 66.32x | 3.8x | 6.24x | 26.14x | 49.96x | 37.51 Mrd. | ||
-.--% | -.--% | 11.47x | 1.29x | 2.58x | 7.21x | 8.25x | 21.3 Mrd. | ||
-.--% | -.--% | 188.84x | 3.17x | 2.72x | 55.27x | 31.71x | 13.98 Mrd. | ||
-.--% | -.--% | -179.22x | 11.17x | 18.72x | -116.52x | -116.7x | 13.53 Mrd. | ||
+0,07% | +0,08% | 333.93x | - | - | - | - | 11.96 Mrd. | ||
-.--% | -.--% | 30.61x | 2.14x | 3.93x | 19.79x | 24.35x | 11.76 Mrd. | ||
-.--% | -.--% | 32.04x | 3.04x | 4.99x | 13.73x | 22.82x | 10.45 Mrd. | ||
+1,93% | +3,42% | 18.39x | 1.61x | 1.18x | 11.41x | 12.34x | 8.03 Mrd. | ||
-.--% | -.--% | -15.37x | -4.76x | 29.39x | -16x | -14.84x | 7.1 Mrd. | ||
-.--% | -.--% | -65.33x | 4.06x | 5.38x | -63.95x | -44.51x | 6.8 Mrd. | ||
+0,22% | +0,22% | 18.68x | 1.44x | 4.63x | 14.92x | 15.96x | 6.3 Mrd. | ||
+0,75% | +0,68% | 30.16x | 3.73x | 6.08x | 14.91x | 16.78x | 5.66 Mrd. | ||
-.--% | +1,79% | 26.68x | 1.04x | 2.06x | 8.36x | 11.8x | 5.67 Mrd. | ||
-.--% | -.--% | -18.98x | 118.52x | 12.74x | -22.04x | -20.31x | 5 Mrd. | ||
-.--% | +0,44% | 41.28x | 12.25x | - | - | - | 4.5 Mrd. | ||
+1,81% | +2,06% | 21.23x | 2.36x | 5.22x | 13.44x | 14.86x | 3.98 Mrd. | ||
Durchschnitt | +0.40% | +0.63% | 35.86x | 10.37x | 8.05x | 1.56x | 5.75x | 17.28 Mrd. | |
Gewichteter Durchschnitt nach Marktkapitalisierung | +0.65% | +0.79% | 45.98x | 6.26x | 8.50x | 13.85x | 21.21x |
- Börse
- Aktien
- A207940 Aktie
- Sektor Samsung Biologics Co.,Ltd.
- branchenspezifische Dividenden
MarketScreener is also available in this country: United States.
Switch edition